HRT Financial’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-54,733
Closed -$158K – 4907
2026
Q1
$158K Sell
54,733
-135,362
-71% -$289K ﹤0.01% 3251
2025
Q4
$306K Buy
+190,095
New +$299K ﹤0.01% 2363
2025
Q3
– Sell
-102,714
Closed -$124K – 3348
2025
Q2
$124K Buy
102,714
+71,544
+230% +$104K ﹤0.01% 2167
2025
Q1
$39K Buy
+31,170
New +$81.4K ﹤0.01% 2256
2024
Q3
– Sell
-75,042
Closed -$318K – 2850
2024
Q2
$318K Buy
+75,042
New +$731K ﹤0.01% 1486
2023
Q4
– Sell
-90,540
Closed -$421K – 2781
2023
Q3
$421K Sell
90,540
-63,534
-41% -$316K ﹤0.01% 1489
2023
Q2
$824K Sell
154,074
-77,853
-34% -$480K 0.01% 1066
2023
Q1
$1.66M Buy
231,927
+92,914
+67% +$560K 0.02% 689
2022
Q4
$932K Sell
139,013
-30,373
-18% -$167K 0.01% 1018
2022
Q3
$586K Sell
169,386
-164,636
-49% -$630K 0.01% 1328
2022
Q2
$985K Buy
+334,022
New +$1.76M 0.01% 947
2022
Q1
– Sell
-73,296
Closed -$1.18M – 3550
2021
Q4
$1.18M Sell
73,296
-20,012
-21% -$377K 0.01% 985
2021
Q3
$1.95M Buy
+93,308
New +$2.25M 0.01% 755
2021
Q2
– Sell
-7,724
Closed -$246K – 3258
2021
Q1
$246K Buy
+7,724
New +$188K ﹤0.01% 2212

Other funds holding MGNX

HRT Financial's MGNX Position: Q2 2026 in Review

HRT Financial sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 54,733 shares — an estimated $158K sold.

HRT Financial first reported a position in MGNX in Q1 2021 and held it in 14 quarters. The position peaked at $1.95M in Q3 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • HRT Financial reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 54,733 MacroGenics shares in Q2 2026, an estimated $158K.
  • HRT Financial first reported a position in MacroGenics in Q1 2021 and held it in 14 quarters.
  • HRT Financial's MacroGenics position peaked at $1.95M in Q3 2021.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.